Live feed
Filing
SC 13G
SC 13G0001493152-17-001736·Evans Daron
Schedule 13G ownership disclosure
Viking Therapeutics Inc
Security class unavailable · CUSIP: 92686J106
Event date: 2017-02-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-17-001736
- Form type
- SC 13G
- Filer
- Evans Daron
- CIK
- CIK 1411726
- Filed
- Feb 17, 2017
- Reporting period
- Feb 08, 2017
- Description
- Schedule 13G beneficial ownership